Testing effectiveness (Phase 2)Study completedNCT00427557What this trial is testingCellular Therapy With Cord Blood CellsWho this might be right forMultiple MyelomaLeukemiaLymphoma M.D. Anderson Cancer Center 31
Testing effectiveness (Phase 2)Study completedNCT00005804What this trial is testingBone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Fred Hutchinson Cancer Center
Early research (Phase 1)Ended earlyNCT04553692What this trial is testingPhase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed CancersWho this might be right forSolid TumorColorectal CancerNon Hodgkin Lymphoma+5 more IGM Biosciences, Inc. 272
Testing effectiveness (Phase 2)Study completedNCT00083187What this trial is testingVNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk MyelodysplasiaWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms Vion Pharmaceuticals 230
Not applicableLooking for participantsNCT06724536What this trial is testingInteraction Between Gut Microbiota and TKIs in Defining the Clinical Outcomes of Patients With CMLWho this might be right forLeukemia,Myeloid, Chronic Carmen Fava 100
Testing effectiveness (Phase 2)Study completedNCT01850004What this trial is testingOpen-Label Study Evaluating Dasatinib Therapy Discontinuation in Patients With Chronic Phase Chronic Myeloid Leukemia With Stable Complete Molecular ResponseWho this might be right forChronic Phase Chronic Myeloid Leukemia Bristol-Myers Squibb 84
Testing effectiveness (Phase 2)Study completedNCT00763763What this trial is testingImatinib Mesylate With Vincristine and Dexamethasone in Acute Lymphoblastic Leukemias With BCR-ABL PositiveWho this might be right forLeukemia, Lymphocytic, AcutePhiladelphia ChromosomeBlast Crisis+1 more Assistance Publique - Hôpitaux de Paris 55
Early research (Phase 1)Looking for participantsNCT03326921What this trial is testingHA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell TransplantWho this might be right forJuvenile Myelomonocytic LeukemiaRecurrent Acute Biphenotypic LeukemiaRecurrent Acute Undifferentiated Leukemia+26 more Fred Hutchinson Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT01165996What this trial is testingDifferentiation Therapy With Decitabine in Treating Patients With Myelodysplastic SyndromeWho this might be right forChronic Myelomonocytic Leukemiade Novo Myelodysplastic SyndromesMyelodysplastic Syndromes+5 more Case Comprehensive Cancer Center 25
Early research (Phase 1)Active Not RecruitingNCT02530034What this trial is testingHu8F4 in Treating Patients With Advanced Hematologic MalignanciesWho this might be right forAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveHematopoietic and Lymphoid Cell Neoplasm+8 more M.D. Anderson Cancer Center 72
Not applicableStudy completedNCT07150793What this trial is testingReal-world Treatment and Burden of Chronic Myeloid Leukemia Patients in JapanWho this might be right forMyeloid Leukemia, Chronic Novartis Pharmaceuticals 754
Not applicableStudy completedNCT05972577What this trial is testingGeriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS StudyWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAplastic Anemia+9 more Ohio State University Comprehensive Cancer Center 30
Large-scale testing (Phase 3)Study completedNCT01231412What this trial is testingGraft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell TransplantWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin Lymphoma+16 more Fred Hutchinson Cancer Center 174
Testing effectiveness (Phase 2)Study completedNCT00425477What this trial is testingBexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid LeukemiaWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 26
Early research (Phase 1)Study completedNCT00077558What this trial is testing3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic SyndromeWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT00003425What this trial is testingPhase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine CytoprotectWho this might be right forBreast CancerLeukemiaLymphoma+4 more University of Kentucky 25
Early research (Phase 1)Study completedNCT02029950What this trial is testingPomalidomide After Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeWho this might be right forAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia-2High Risk Myelodysplastic Syndrome+1 more National Cancer Institute (NCI) 50
Not applicableLooking for participantsNCT05130138What this trial is testingInterest of PHARMaceutical Conciliation to Understand Drug Interactions, Phytotherapy, and Targeted Therapies in Chronic Myeloid LeukemiaWho this might be right forChronic Myeloid Leukemia Centre Hospitalier Universitaire de Saint Etienne 100
Not applicableStudy completedNCT02363868What this trial is testingHealthcare Costs Among Patients With CML Receiving Dasatinib or Nilotinib in a Commercial and Medicare PopulationWho this might be right forChronic Myeloid Leukemia (CML) Bristol-Myers Squibb 186
Testing effectiveness (Phase 2)WithdrawnNCT00004878What this trial is testingDonor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid LeukemiaWho this might be right forGraft Versus Host DiseaseLeukemia Jonsson Comprehensive Cancer Center